Epidemiology of invasive group a streptococcal infections in the United States, 2005-2012

Clinical Infectious Diseases

Volumn 63, Issue 4, 2016, Pages 478-486

  Nelson, George E ^a,b,d   Pondo, Tracy ^b   Toews, Karrie Ann ^b   Farley, Monica M ^c   Lindegren, Mary Lou ^d   Lynfield, Ruth ^e   Aragon, Deborah ^f   Zansky, Shelley M ^g   Watt, James P ^h   Cieslak, Paul R ⁱ   Angeles, Kathy ^j   Harrison, Lee H ^k   Petit, Susan ^l   Beall, Bernard ^b   Van Beneden, Chris A ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e MINNESOTA DEPARTMENT OF HEALTH   (United States)

^f Colorado Department of Public Health and Environment ^*  (United States)

^g NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^h California Department of Public Health   (United States)

ⁱ OREGON HEALTH AUTHORITY   (United States)

^j UNIVERSITY OF NEW MEXICO   (United States)

^k JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^l CDC   (United States)

more..

Author keywords

Epidemiology; Group a Streptococcus; Streptococcal toxic shock syndrome; Surveillance; Vaccine

Indexed keywords

STREPTOCOCCUS VACCINE;

ABDOMINAL INFECTION; ABSCESS; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLACK PERSON; CALIFORNIA; CAUCASIAN; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; CHRONIC DISEASE; COLORADO; CONNECTICUT; ENDOCARDITIS; EPIGLOTTITIS; FEMALE; GEORGIA (U.S.); GROUP A STREPTOCOCCAL INFECTION; GROUPS BY AGE; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MARYLAND; MENINGITIS; MINNESOTA; NECROTIZING FASCIITIS; NEW MEXICO; NEW YORK; NEWBORN; NONHUMAN; NURSING HOME; OREGON; OSTEOMYELITIS; OTITIS MEDIA; PATIENT HISTORY OF SURGERY; PERICARDITIS; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SEPTIC SHOCK; TENNESSEE; TOXIC SHOCK SYNDROME; WOUND; CLASSIFICATION; EPIDEMIOLOGICAL MONITORING; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MORBIDITY; PUBLIC HEALTH SERVICE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BACTEREMIA; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); EPIDEMIOLOGICAL MONITORING; FASCIITIS, NECROTIZING; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORBIDITY; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; UNITED STATES; YOUNG ADULT;

EID: 84982131747     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw248     Document Type: Review

References (42)

1. O'Brien KL, Beall B, Barrett NL, et al. Epidemiology of invasive group A Streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002; 35:268-76
2. O'Loughlin RE, Roberson A, Cieslak PR, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007; 45:853-62
3. Department of Child and Adolescent Health and Development, World Health Organization. The current evidence for the burden of group A streptococcal diseases. Geneva, Switzerland: World Health Organization, 2005
4. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5:685-94
5. Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 2007; 44:705-10
6. Prevention of Invasive Group ASIWP. Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis 2002; 35:950-9
7. Public Health Agency of Canada. Guidelines for the Prevention and Control of Invasive Group A streptococcal disease. CCDR 2006; 32S2:1-26
8. McNeil SA, Halperin SA, Langley JM, et al. Safety and immunogenicity of 26-valent group A Streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 2005; 41:1114-22
9. Hu MC, Walls MA, Stroop SD, Reddish MA, Beall B, Dale JB. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun 2002; 70:2171-7
10. McMillan D. StreptAvax (ID Biomedical). Curr Opin Investig Drugs 2006; 7:186-90
11. Kotloff KL, Dale JB. Progress in group A streptococcal vaccine development. Pediatr Infect Dis J 2004; 23:765-6
12. Dale JB, Penfound TA, Chiang EY, Walton WJ. New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine 2011; 29:8175-8
13. Langley G, Schaffner W, Farley MM, et al. Twenty years of active bacterial core surveillance. Emerg Infect Dis 2015; 21:1520-8
14. Centers for Disease Control and Prevention. Active Bacterial Core surveillance (ABCs). Surveillance reports. Available at: http://www.cdc.gov/abcs/reportsfindings/ surv-reports.html. Accessed February 2016
15. Centers for Disease Control and Prevention. Protocol for emm typing. Available at: http://www.cdc.gov/streplab/protocol-emm-type.html. Accessed November 2014
16. Centers for Disease Control and Prevention. Streptococcus pyogeness emm sequence database. 2011
17. Laupland KB, Ross T, Church DL, Gregson DB. Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region. Clin Microbiol Infect 2006; 12:224-30
18. Lamagni TL, Darenberg J, Luca-Harari B, et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2008; 46:2359-67
19. Vlaminckx BJ, van Pelt W, Schouls LM, et al. Long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1994-2003. Clin Microbiol Infect 2005; 11:226-31
20. Lepoutre A, Doloy A, Bidet P, et al. Epidemiology of invasive Streptococcus pyogenes infections in France in 2007. J Clin Microbiol 2011; 49:4094-100
21. Montes M, Ardanuy C, Tamayo E, Domenech A, Linares J, Perez-Trallero E. Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998-2009): comparison with non-invasive isolates. Eur J Clin Microbiol Infect Dis 2011; 30:1295-302
22. Steer AC, Jenney A, Kado J, et al. Prospective surveillance of invasive group A streptococcal disease, Fiji, 2005-2007. Emerg Infect Dis 2009; 15:216-22
23. Norton R, Smith HV,Wood N, Siegbrecht E, Ross A, Ketheesan N. Invasive group A streptococcal disease in North Queensland (1996-2001). Indian J Med Res 2004; 119(suppl):148-51
24. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005; 352:39-47
25. Williamson DA, Morgan J, Hope V, et al. Increasing incidence of invasive group A Streptococcus disease in New Zealand, 2002-2012: a national population-based study. J Infect 2015; 70:127-34
26. Olafsdottir LB, Erlendsdottir H, Melo-Cristino J, et al. Invasive infections due to Streptococcus pyogenes: seasonal variation of severity and clinical characteristics, Iceland, 1975 to 2012. Euro Surveill 2014; 19:5-14
27. Darenberg J, Henriques-Normark B, Lepp T, Tegmark-Wisell K, Tegnell A, Widgren K. Increased incidence of invasive group A streptococcal infections in Sweden, January 2012-February 2013. Euro Surveill 2013; 18:20443
28. Meehan M, Murchan S, Bergin S, O'Flanagan D, Cunney R. Increased incidence of invasive group A streptococcal disease in Ireland, 2012 to 2013. Euro Surveill 2013; 18:20556
29. Thigpen MC, Richards CL Jr, Lynfield R, et al. Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003. Emerg Infect Dis 2007; 13:1852-9
30. Vincent GK, Velkoff VA. The next four decades: the older population in the United States: 2010 to 2050. Current population reports P25-1138. Washington, DC: US Census Bureau, 2010
31. Moreland NJ, Waddington CS, Williamson DA, et al. Working towards a group A streptococcal vaccine: report of a collaborative Trans-Tasman workshop. Vaccine 2014; 32:3713-20
32. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 2009; 9:611-6
33. Dale JB, Penfound TA, Tamboura B, et al. Potential coverage of a multivalent M protein-based group A streptococcal vaccine. Vaccine 2013; 31:1576-81
34. Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS). Streptococcal toxic shock syndrome (STSS) (Streptococcus pyogenes): 2010 case definition. Available at: http://wwwn.cdc.gov/nndss/ conditions/streptococcal-toxic-shock-syndrome/case-definition/2010. Accessed November 2015
35. Carapetis JR, Jacoby P, Carville K, Ang SJ, Curtis N, Andrews R. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group A streptococcal infections. Clin Infect Dis 2014; 59:358-65
36. Jordan HT, Richards CL Jr, Burton DC, Thigpen MC, Van Beneden CA. Group A streptococcal disease in long-term care facilities: descriptive epidemiology and potential control measures. Clin Infect Dis 2007; 45:742-52
37. Beaudoin AL, Torso L, Richards K, et al. Invasive group A Streptococcus infections associated with liposuction surgery at outpatient facilities not subject to state or federal regulation. JAMA Intern Med 2014; 174:1136-42
38. Dooling KL, Crist MB, Nguyen DB, et al. Investigation of a prolonged group A streptococcal outbreak among residents of a skilled nursing facility, Georgia, 2009-2012. Clin Infect Dis 2013; 57:1562-7
39. Stevens DL. Invasive group A Streptococcus infections. Clin Infect Dis 1992; 14:2-11
40. Factor SH, Levine OS, Schwartz B, et al. Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis 2003; 9:970-7
41. Cowgill KD, Van Beneden Chris, Wright C, Beall B, Schuchat A; Active Bacterial Core Surveillance Team. Burden of streptococcal toxic shock syndrome and necrotizing fasciitis-United States, 2002 [abstract 238]. Program and abstracts of the 43rd Annual Meeting of the Infectious Diseases Society of America. San Diego, California: Alexandria, VA: Infectious Diseases Society of America, 2003:71, 2002
42. Shulman ST, Tanz RR, Dale JB, et al. Seven-year surveillance of North American pediatric group A streptococcal pharyngitis isolates. Clin Infect Dis 2009; 49:78-84